Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hainan Province
- Most recent report
- 10-Q, filed Aug 14, 2026
- Incorporated
- Delaware
- Filings on record
- 425 filings
- On EDGAR
- CIK 1106644
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 91
News 8 of 77
- 8-K Significant contract Jul 22, 2026
- 8-K Significant contract Mar 3, 2026
- 8-K Significant contract Feb 10, 2026
- 8-K Shareholder vote results Jan 6, 2026
- 8-K Significant contract Dec 23, 2025
- 8-K Significant contract Dec 10, 2025
- 8-K Current report on a material event Apr 4, 2025
- 8-K Current report on a material event Dec 26, 2024
Prospectuses and Registrations 8 of 20
- 424B5 Prospectus supplement for an offering Jul 23, 2026
- 424B5 Prospectus supplement for an offering Dec 13, 2024
- S-3/A Shelf registration statement, amended Feb 6, 2024
- S-3 Shelf registration statement Jan 12, 2024
- S-8 Registration statement for an employee plan Oct 24, 2022
- 424B5 Prospectus supplement for an offering Dec 16, 2021
- S-3 Shelf registration statement Jan 8, 2021
- S-8 Registration statement for an employee plan Dec 21, 2020
Proxies 8 of 31
- DEF 14A Proxy statement for a shareholder vote Nov 14, 2025
- PRE 14A Preliminary proxy statement Nov 4, 2025
- DEF 14A Proxy statement for a shareholder vote Nov 12, 2024
- PRE 14A Preliminary proxy statement Nov 1, 2024
- DEF 14A Proxy statement for a shareholder vote Nov 7, 2023
- PRE 14A Preliminary proxy statement Oct 27, 2023
- DEF 14A Proxy statement for a shareholder vote Nov 14, 2022
- PRE 14A Preliminary proxy statement Nov 4, 2022
Ownership 8 of 58
- SC 13G Large holder reported a passive stake Jan 26, 2024
- 3 Insider reported their initial holding Jan 26, 2024
- SC 13G/A Large holder reported a passive stake, amended Jan 12, 2024
- 4 Insider reported a trade Oct 19, 2023
- SC 13G Large holder reported a passive stake Mar 9, 2023
- 3 Insider reported their initial holding Mar 9, 2023
- SC 13G/A Large holder reported a passive stake, amended Dec 5, 2022
- SC 13G Large holder reported a passive stake Sep 27, 2022
Other 8 of 148
- NT 10-K Notice that an annual report will be late Apr 1, 2026
- EFFECT Notice that a registration became effective Feb 14, 2024
- CORRESP Reply to SEC staff Feb 14, 2024
- CORRESP Reply to SEC staff Feb 6, 2024
- UPLOAD Comment letter from SEC staff Jan 25, 2024
- UPLOAD Comment letter from SEC staff Nov 16, 2023
- CORRESP Reply to SEC staff Nov 9, 2023
- UPLOAD Comment letter from SEC staff Oct 27, 2023
Everything here comes from China Pharma Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.